Emina Torlakovic

7PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 18, 2026
Efficacy of actinium-225-labeled fully human anti-MUC-16 radioimmunoconjugate against MUC-16-positive ovarian and pancreatic ductal adenocarcinoma xenograft models.

|Apr 27, 2026
"HER2-Low" and the Challenge of Repurposing Legacy HER2 IHC Biomarker Assays.

|Feb 01, 2026
Despite simplified diagnostic criteria, intraobserver and interobserver variability remain in the interpretation of colorectal serrated polyps.

Adam L Booth, Emina E Torlakovic, Runjan Chetty

|Jul 16, 2025
Indirect clinical validation for predictive biomarkers in oncology: International Quality Network for Pathology (IQN Path) Position Paper.

Emina E Torlakovic, Raed Al Dieri, Tony Badrick

|Mar 24, 2025
An Anti-EGFR Antibody-Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Antitumor Responses in KRAS- and BRAF-Mutant Colorectal Cancer.

Anjong Florence Tikum, Nikita W Henning, Jessica Pougoue Ketchemen

|Dec 21, 2024
Clinical Applications of Bone Marrow CD34 Immunohistochemistry (BM CD34 IHC) Assay: International Council for Standardization in Hematology (ICSH) Guidelines.

Emina Emilia Torlakovic, Katherine R Calvo, Tracy George

Pageof 2

Frequent Collaborators

2 joint publications

Fabrice Ngoh Njotu

2 joint publications

Maruti Uppalapati

2 joint publications

Emmanuel Nwangele

2 joint publications

Hanan Babeker